礼来联合信达生物宣布达伯舒联合化疗用于一线治疗胃及胃食管交界处腺癌获NMPA批准上市

array(1) { [404235]=> array(2) { [2]=> array(5) { [0]=> string(6) "中国" [1]=> string(12) "信达生物" [2]=> string(12) "单抗概念" [3]=> string(6) "礼来" [4]=> string(18) "肿瘤免疫治疗" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }